Latest Insider Transactions at Adc Therapeutics Sa (ADCT)
This section provides a real-time view of insider transactions for Adc Therapeutics Sa (ADCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADC Therapeutics SA to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADC Therapeutics SA's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.38%
|
$300,000
$3.05 P/Share
|
|
Dec 11
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.32%
|
$300,000
$3.05 P/Share
|
|
Dec 06
2024
|
Mohamed Zaki Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,112
-13.75%
|
$111,336
$3.13 P/Share
|
|
Dec 06
2024
|
Peter J Graham Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,458
-18.03%
|
$124,374
$3.13 P/Share
|
|
Dec 06
2024
|
Jose Carmona Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,108
-13.75%
|
$144,324
$3.13 P/Share
|
|
Dec 06
2024
|
Lisa Michelle Kallebo Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,503
-15.3%
|
$19,509
$3.13 P/Share
|
|
Dec 06
2024
|
Ameet Mallik Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
238,343
-20.42%
|
$715,029
$3.13 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
50,672
+0.39%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
50,672
+0.32%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
50,672
-0.33%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,352
-0.16%
|
$50,704
$2.07 P/Share
|
|
Jul 01
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400,000
+2.99%
|
$800,000
$2.81 P/Share
|
|
Jul 01
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+2.49%
|
$800,000
$2.81 P/Share
|
|
Jun 17
2024
|
Robert Azelby Director |
SELL
Open market or private sale
|
Direct |
6,995
-11.66%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Viviane Monges Director |
SELL
Open market or private sale
|
Direct |
1,437
-1.33%
|
$2,874
$2.89 P/Share
|
|
Jun 17
2024
|
Peter Hug Director |
SELL
Open market or private sale
|
Direct |
1,193
-0.65%
|
$2,386
$2.89 P/Share
|
|
Jun 17
2024
|
Jean Pierre Bizzari Director |
SELL
Open market or private sale
|
Direct |
6,995
-8.09%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Ron Squarer Director |
SELL
Open market or private sale
|
Direct |
6,995
-7.98%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Victor Sandor Director |
SELL
Open market or private sale
|
Direct |
6,995
-7.96%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Thomas Pfisterer Director |
SELL
Open market or private sale
|
Direct |
1,437
-0.67%
|
$2,874
$2.89 P/Share
|
|
Jun 13
2024
|
Robert Azelby Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+40.0%
|
-
|
|
Jun 13
2024
|
Peter Hug Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+17.87%
|
-
|
|
Jun 13
2024
|
Jean Pierre Bizzari Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.62%
|
-
|
|
Jun 13
2024
|
Thomas Pfisterer Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+15.67%
|
-
|
|
Jun 13
2024
|
Victor Sandor Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.28%
|
-
|
|
Jun 13
2024
|
Ron Squarer Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.33%
|
-
|
|
Jun 13
2024
|
Viviane Monges Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.02%
|
-
|
|
May 07
2024
|
Ameet Mallik Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,731
-2.48%
|
$118,924
$4.48 P/Share
|